Literature DB >> 35882820

In Vivo Sex-Dependent Effects of Perinatal Pb2+ Exposure on Pilocarpine-Induced Seizure Susceptibility and Taurine Neuropharmacology.

Michelle A Vasquez1,2, George B Cruz2,3, Ericka Cabañas2,3, Jewel N Joseph2,3, Mohammad Mian2,3, Sai Karthik V Madhira2,3, Chelsea A Akintunde2,3, Evan G Clarke2,3, Jourvonn C Skeen2,3, Jalen R Bonitto2,3, Eric B Khairi2,3, Kirsten P Lynch2,4, Narmin H Mekawy5,6, Abdeslem El Idrissi5,6, Youngjoo Kim1, Bright U Emenike1, Lorenz S Neuwirth7,8.   

Abstract

Lead (Pb2+) is a developmental neurotoxicant that disrupts the GABA-shift and subsequently causes alterations in the brain's excitation-to-inhibition (E/I) balance. This finding suggests that neurodevelopmental Pb2+ exposures may increase the risk of brain excitability and/or seizure susceptibility. Prior studies have suggested that neurodevelopmental Pb2+ exposures may cause excitotoxicity of cholinergic neurons, but little to no research has further investigated these potential relationships. The present study sought to evaluate the potential for perinatal neurodevelopmental Pb2+ exposures of 150 ppm and 1000 ppm on pilocarpine-induced seizures through the M1 receptor. The study also evaluated the potential for sex- and treatment-dependent differences in brain excitability. The study revealed that Control females have elevated cholinergic brain excitability and decreased GABAergic inhibition in response to pilocarpine-induced seizures. At low Pb2+ exposures, males exhibited more cholinergic brain excitability, whereas at higher Pb2+ exposures, females exhibited more cholinergic brain excitability. Further, taurine was able to provide neuroprotection against pilocarpine-induced seizures in males, whereas females did not reveal such observations. Thus, the present study adds new insights into the potential for cholinergic seizure susceptibility as a function of sex and the dosage ofneurodevelopmental Pb2+ exposure and how taurine may provide selective pharmacodynamics to treat or recover cholinergic system aberrations induced by neurotoxicants.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Anxiety-like behaviors; Anxiolytic drugs; Developmental lead exposure; GABAergic system; Lead poisoning; Taurine derivatives

Mesh:

Substances:

Year:  2022        PMID: 35882820     DOI: 10.1007/978-3-030-93337-1_44

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  79 in total

1.  Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter.

Authors:  Richard L Canfield; Charles R Henderson; Deborah A Cory-Slechta; Christopher Cox; Todd A Jusko; Bruce P Lanphear
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

Review 2.  The GABA excitatory/inhibitory shift in brain maturation and neurological disorders.

Authors:  Yehezkel Ben-Ari; Ilgam Khalilov; Kristopher T Kahle; Enrico Cherubini
Journal:  Neuroscientist       Date:  2012-04-30       Impact factor: 7.519

Review 3.  Low-level lead exposure and cognitive function in children.

Authors:  D Bellinger; K N Dietrich
Journal:  Pediatr Ann       Date:  1994-11       Impact factor: 1.132

4.  Psychiatric and neurodevelopmental disorders in childhood-onset epilepsy.

Authors:  Anne T Berg; Rochelle Caplan; Dale C Hesdorffer
Journal:  Epilepsy Behav       Date:  2011-02-18       Impact factor: 2.937

5.  Differential contribution of current and cumulative indices of lead dose to neuropsychological performance by age.

Authors:  M L Bleecker; K N Lindgren; D P Ford
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

6.  Developmental cholinotoxicity of lead: loss of septal cholinergic neurons and long-term changes in cholinergic innervation of the hippocampus in perinatally lead-exposed rats.

Authors:  N Bourjeily; J B Suszkiw
Journal:  Brain Res       Date:  1997-10-17       Impact factor: 3.252

7.  Taurine, taurine analogues, and taurine functions: overview.

Authors:  L Bianchi; M A Colivicchi; C Ballini; M Fattori; C Venturi; M G Giovannini; J Healy; K F Tipton; L Della Corte
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

8.  Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study.

Authors:  D C Bellinger; K M Stiles; H L Needleman
Journal:  Pediatrics       Date:  1992-12       Impact factor: 7.124

Review 9.  Developmental neurotoxicants in e-waste: an emerging health concern.

Authors:  Aimin Chen; Kim N Dietrich; Xia Huo; Shuk-mei Ho
Journal:  Environ Health Perspect       Date:  2010-11-15       Impact factor: 9.031

Review 10.  A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs.

Authors:  Fernando Barbosa; José Eduardo Tanus-Santos; Raquel Fernanda Gerlach; Patrick J Parsons
Journal:  Environ Health Perspect       Date:  2005-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.